Find Academic Supervisors

Professor Jiyuan Tu is a Professor in the Department of Mechanical and Automotive Engineering at RMIT University's School of Engineering. He specializes in computational fluid dynamics (CFD), multiphase flows, and their applications in renewable/nuclear energy, biomedical engineering, and built environment systems. His research has led to over 500 peer-reviewed articles, 9 books, and $10M+ in ARC grants. He has supervised over 50 postgraduate students and received prestigious awards such as the RMIT Research Excellence Award (2012) and Fulbright Senior Scholar Award (2008). Research interests include CFD modelling of bioaerosol transport, drug delivery systems, and thermal energy storage. He pioneered numerical models for multiphase flows, contributing to software implementations in industries. Notable works include books on CFD and multiphase flow analysis, and leadership in international conferences like COBEE 2018. He holds honorary professorships at Tsinghua University and is Editor-in-Chief of the Experimental and Computational of Multiphase Flow journal. Industry experience includes roles at ANSTO (1996-2001). Awards span fellowships from JSPS, KOSEF, and Fulbright programs. Grants include ARC Discovery, Linkage, and LIEF projects. His work ranks him among the world’s top researchers in pebble bed reactors and airborne infection studies (SciVal 2016-2025).

• Computational Fluid Dynamics (CFD)
• Multiphase Flows
• Thermal Sciences
• +4 more

Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.

• Small Molecule Drug Discovery
• Cancer Therapeutics
• Pharmaceutical Chemistry
• +3 more

Dr. Yogambha Ramaswamy is a Senior Lecturer in the School of Biomedical Engineering at The University of Sydney and a member of the Sydney Nano Institute. She holds a Master’s in Biotechnology from the University of Queensland and a PhD in Biomedical Engineering from the University of Sydney (2009). Her postdoctoral career began as a Vice-Chancellor’s Postdoctoral Research Fellow at the University of New South Wales, followed by a Peter Doherty Early Career Fellowship in 2013 before joining the University of Sydney in 2015. Dr. Ramaswamy’s research focuses on biomaterials, tissue engineering, and mechanobiology, with a particular emphasis on developing calcium silicate-based ceramics and biopolymers for orthopedic and regenerative applications. Her recent work explores the role of physical cues in modulating stem and cancer cell behavior. She teaches courses such as AMME1961 (Introduction to Biomedical Engineering B) and AMME5962 (Introduction to Mechanobiology). Her research has been supported by grants including the NHMRC Early Career Fellowship and collaborations with institutions like the CSIR-Indian Institute of Chemical Technology and the University of Otago. Her publications span biomaterials, nanotechnology, and mechanobiology, with recent work addressing atherosclerosis, hydrogel design, and nanomedicine. She currently supervises PhD students Frank (biomaterials) and Alexander (atherosclerosis research).

• Biomaterials
• Tissue Engineering
• Mechanobiology
• +3 more

Dr. Susan Hua is an Associate Professor at the University of Newcastle's School of Biomedical Sciences and Pharmacy, specializing in translational nanopharmaceutics and therapeutic targeting. She established the first translational nanopharmaceutics laboratory in the Hunter region, focusing on drug delivery systems for gastrointestinal, musculoskeletal, and reproductive pathologies. Education: Bachelor of Pharmacy with Honours, University of Queensland (UQ) PhD in Neuroscience and Nanotechnology, UQ Research Interests: Her work centers on using nanotechnology to create targeted drug delivery systems for diseases such as chronic pain, inflammatory conditions, and obstetric complications. Key focuses include oxytocin receptor-targeted liposomes for uterine therapies and localized drug delivery to bypass biological barriers. Awards & Recognition: 2020 DVC(A) Educator Innovation Award 2017 NSW Premier's Early Career Researcher of the Year 2015 HMRI Early Career Researcher of the Year Grants & Collaborations: A/Prof Hua has secured over $5.5M in grants, including NHMRC and ARC funding. She collaborates with institutions like HMRI, John Hunter Hospital, and global teams on projects like nanoparticle-based treatments for preterm labor and uterine hemorrhage. Teaching & Leadership: She coordinates pharmacy programs, emphasizing clinical application and innovation. Her courses include Pharmacotherapeutics and Pharmacy Practice, with awards for teaching excellence (2020, 2011). Labs & Programs: Head of Therapeutic Targeting Program, University of Newcastle Director, Translational Pharmaceutics & Medical Technologies Theme (HMRI)

• Nanomedicine
• Therapeutic Targeting
• Drug Delivery Systems
• +4 more

About Dr. Pegah Varamini Dr. Pegah Varamini is a Senior Lecturer in Pharmacy and Pharmacology at the Sydney Pharmacy School, University of Sydney, and a Casual Lecturer in Music Education at the Sydney Conservatorium of Music. She leads the Breast Cancer Targeting & Drug Delivery (BCTDD) Group, focusing on innovative drug delivery systems for Triple Negative Breast Cancer (TNBC). Her research integrates nanotechnology, targeted therapy, and translational medicine, supported by prestigious grants including the NBCF Fellowship (2016). Research & Education PharmD (Shiraz University of Medical Sciences) PhD in Pharmaceutical Sciences (University of Queensland) Second PhD in Music Education (University of Sydney Conservatorium of Music) Key Research Interests Her work centers on: Peptide-based targeting strategies using 'Trojan Horse' approaches for TNBC Development of nanomedicine for bone metastasis prevention Clinically relevant preclinical models for personalized breast cancer treatment Collaborations with international institutions (e.g., Harvard Medical School, University of Nantes) Teaching & Supervision Dr. Varamini coordinates Drug Design and Development (PCOL3012/3912) and supervises a multidisciplinary team of HDR students and postdoctoral researchers. Notable current students include PhD candidate Hany Ghaly and MPhil candidates Huimin Shao and Farhana Mollah. Awards & Recognition 2021 Equity Prize 2016 Top 25 Young Researchers of Australia and New Zealand 2018 Fresh Scientist of the Year Recipient of multiple grants totaling over AUD 2M Leadership & Outreach She co-chairs the Nanopharma cluster at Sydney Nano Institute and advises the WHO Global Breast Cancer Initiative. Her work has been featured in media outlets such as SBS Farsi News and NBCF publications.

• Cancer Targeting
• Drug Design
• Drug Delivery
• +4 more

Professor Robert McLaughlin is a faculty member in the School of Biomedicine at the University of Adelaide, affiliated with the Faculty of Health and Medical Sciences. He leads the Bioengineering Imaging Group and serves as Managing Director of the start-up Miniprobes. His research focuses on developing optical imaging technologies, including non-invasive tools for blood flow assessment and miniaturized imaging probes. He has secured over $14M in research grants and holds an h-index of 45 with 98 journal papers, 7 patents, and 2 book chapters. Prof. McLaughlin’s career includes roles at the University of Oxford and Siemens Medical Solutions, followed by academic leadership since 2007. His innovations span optical coherence tomography (OCT), fluorescence imaging, and dual-modality systems for clinical applications. Awards include the 2014 WA Innovator of the Year, 2015 Australian Innovation Challenge, and 2016 South Australian Premier’s Research Fellowship. His research emphasizes practical medical solutions, such as imaging needles for deep-tissue diagnostics and optical devices for real-time surgical monitoring. The Bioengineering Imaging Group collaborates with industry and academia to translate technologies into clinical practice.

• Optical Imaging
• Biomedical Engineering
• Medical Devices
• +3 more

Dr. Nhiem Tran is a Senior Lecturer in the Department of Applied Chemistry and Environmental Science at RMIT University's School of Science, part of the STEM College. He joined RMIT in 2015 as a Vice Chancellor's Research Fellow after completing his PhD in Physics at Brown University (USA, 2012) and postdoctoral research at Rhode Island Hospital (USA), CSIRO, and the Australian Synchrotron. His research focuses on developing biomaterials for drug delivery, gene therapy, and medical implants, particularly lipid nanoparticles and 3D-printed metallic implants. He leads the Biomaterial Interfaces group, investigating self-assembled lipid nanoparticles for cancer and autoimmune disease treatments. His work has resulted in over 65 high-impact publications and numerous awards, including the RMIT Vice Chancellor's Research Fellowship and the Stein/Bellet Foundation Fellowship. Tran's funding comes from grants such as the ARC Discovery Project, mRNA Victoria, and the CASS Foundation. His research interests span nanomedicine, biomedical engineering, and materials science, with a focus on applications in drug delivery, bacterial infection control, and orthopaedic implants. Education: PhD in Physics (Brown University, 2012) Key Projects: 3D-printed diamond-titanium implants, lipid nanoparticle drug carriers, and antimicrobial coatings. He actively supervises postgraduate research in areas like nanomaterials for drug delivery and biomedical applications.

• Biomedical Engineering
• Nanotechnology
• Nanomedicine
• +12 more

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +12 more

Lee Yong Lim is a Professor of Pharmaceutics at The University of Western Australia (UWA), leading the Laboratory for Drug Delivery. She specializes in innovative drug delivery systems, particularly for pediatric populations and marine aquaculture. Her work focuses on overcoming medication challenges for children through taste-masked formulations and stable drug-loaded scaffolds for ear diseases. She has secured over $4.5 million in research grants from diverse funding bodies. Education: BSc (Pharmacy) Hons, National University of Singapore PhD, University of Manchester Research: Her team developed a patented chocolate-based formulation for bitter drugs and conducts pediatric trials. Collaborations include WA hospitals for safe compounded medicines and international projects in nanotechnology. Key research areas include pediatric medicinal products, veterinary drug delivery, and sustainable drug formulations aligned with UN SDGs. Grants & Funding: Major supporters include NHMRC, ARC, Telethon, and industry partnerships. Current active grants focus on pre-procedural chewables for children and perioperative analytics. Labs/Teams: Heads the Laboratory for Drug Delivery and collaborates with the Centre for Optimisation of Medicines and Institute for Paediatric Perioperative Excellence.

• Drug Delivery Systems
• Pediatric Medicinal Products
• Taste-Masked Medicines
• +4 more

Craig Jin is an Associate Professor at the University of Sydney, leading the CARlab (Computing and Audio Research Laboratory) and Spatial Audio Research initiatives within the School of Electrical and Computer Engineering. He holds a BS from Stanford University, an MS from Caltech, and a PhD from the University of Sydney. His work focuses on immersive audio technologies, biomedical signal processing, and assistive technologies for sensory augmentation. Research interests include spatial audio reproduction, binaural processing, acoustic sensing for accessibility, and machine learning applications in signal processing. Key contributions span HRTF interpolation, noise reduction algorithms, and acoustic touch systems for the visually impaired. Recent projects include real-time MRI analysis of vocal tract dynamics and sparse recovery techniques for sound field reconstruction. His publications span over 150 peer-reviewed articles in journals like IEEE Transactions on Audio, Speech, and Language Processing, and conferences such as ICASSP. He advises four current PhD/Master’s students on projects like predictive gesture tracking, voice disorder classification, and magnetic resonance imaging techniques.

• Audio Signal Processing
• Spatial Audio Technology
• Medical Engineering
• +3 more

Dr. Yi Shen is a Senior Lecturer at the School of Chemical and Biomolecular Engineering, The University of Sydney, and Chair of RACI Women in Chemistry. She is also affiliated with multiple research institutes including Sydney Institute of Agriculture, Sydney Southeast Asia Centre, The Centre for Drug Discovery Innovation, and The University of Sydney Nano Institute. PhD in Soft Materials from ETH Zurich Postdoctoral research at University of Cambridge and Harvard University Her research focuses on protein phase behavior and functional biomaterials development, utilizing soft matter approaches and microfluidic techniques to address challenges in neurodegenerative diseases, sustainable materials, and biomedical engineering. She has published extensively in top journals like Nature Nanotechnology and PNAS, with a particular emphasis on: Protein liquid-liquid phase separation mechanisms Biomaterials from protein nanofibrils Microfluidic manipulation of biological systems Biodegradable bioplastics development Shear force effects on biomolecular systems Pathological protein aggregation dynamics Key scientific achievements include: 2022 ARC DECRA Fellowship 2022 Sydney Nano Frontier award 2018 ETH Zurich Spark Award (for Fe delivery system invention) 2012 Princeton Grand Challenges Program 2 patents pending 2 Nature Nanotechnology cover articles As an educator, she coordinates CHNG2802 Chemical Engineering Modelling and Analysis, co-teaches CHNG3804 Biochemical Engineering and CHNG5605 Bio-products: Laboratory to Marketplace, and guest lectures across biomedical and nanotechnology programs. Her lab actively collaborates with institutions in Switzerland (ETH Zurich), UK (Cambridge), and US (Harvard, Princeton), focusing on transforming biomolecular understanding into real-world applications in health, industry, and environmental sustainability.

• Protein Biophysics
• Soft Materials
• Microfluidics
• +5 more

Dr. Suresh Bhargava is a Distinguished Professor and Director of AcSIR at RMIT University's Research & Innovation department. He has led interdisciplinary research in materials science, catalysis, and environmental engineering for over three decades, with a focus on strengthening Indo-Australian scientific collaboration. His work bridges academia and industry, addressing challenges in pollution control, nanotechnology, and cancer treatment. Research & Leadership: Established RMIT's Centre for Advanced Materials and Industrial Chemistry (CAMIC), pioneering translational research with industry applications. Supervised 70+ PhD students (100% employment rate), many now leading roles at global institutions. Holds distinguished professorships across six countries and advises governments and Fortune 500 firms on environmental and industrial issues. Awards & Recognition: Recipient of Australia's Member of the Order of Australia (2022), India's P.C. Ray Chair (2014), and the Khwarizmi International Award (2016). His work on mercury pollution control and gold-based anticancer drugs has garnered global acclaim, with over 800 publications (26,000+ citations, h-index 86). Key Contributions: Architect of the Australia-India Strategic Research Fund and the RMIT-AcSIR Joint Research Program. Innovated eco-friendly graphene production from eucalyptus bark and patented anti-cancer gold compounds. Advises on sustainable mineral processing, hydrogen energy, and CO₂ valorization. Industry Engagement: Consulted for Rio Tinto, BHP Billiton, and CSIRO on resource efficiency, pollution mitigation, and nanotechnology applications. His research has created jobs and driven innovation in Australia and Asia-Pacific.

• Catalysis
• Nanotechnology
• Environmental Chemistry
• +3 more

Prof. Ivan Cole is an Adjunct Professor at RMIT University's School of Engineering, specializing in rapid materials discovery for corrosion protection, nanostructures, and additive manufacturing. His work integrates computational modeling with high-throughput experimentation, focusing on corrosion inhibitors, biocompatible surfaces, and additive manufacturing process optimization. With over 30 years of experience across academia and industry (including leadership roles at CSIRO and Centro-Svilluppo Materiali), he leads the Rapid Discovery & Fabrication Team (RDF) to advance these research areas. Research Interests: Corrosion science, microbially induced corrosion (MIC), additive manufacturing surfaces, nanostructure sensing, multiscale modeling, and green materials discovery. His team addresses challenges in corrosion protection, biomedical implants, and environmental remediation through innovative methodologies. Awards: 2019 Australian Corrosion Medal 2016 CSIRO Lifetime Achievement Award 2013 Best Paper in NACE Corrosion Supervision & Projects: Active in mentoring PhD/Master’s students across corrosion inhibition, additive manufacturing, and nanostructure design. Notable projects include developing quorum sensing inhibitors for biofilm control, in-situ monitoring for metal AM, and eco-friendly corrosion inhibitors. Labs & Collaborations: Leads the Rapid Discovery & Fabrication Team and collaborates with industry partners to translate research into practical solutions for materials durability and sustainability.

• Corrosion Science
• Multiscale Modelling
• Additive Manufacturing
• +7 more

Dr. Jannah Baker is a Research Fellow at the Sydney School of Public Health, University of Sydney. She holds a PhD in Statistics specializing in Bayesian spatiotemporal modelling of chronic diseases, alongside dual postgraduate diplomas in Public Health and Statistics. Her clinical background includes five years as a practicing physician. Her research focuses on cancer prevention (breast, endometrial, melanoma), spatiotemporal disease modeling, health economics, and clinical trial design. She has led projects on sepsis detection systems, diabetes management, and surgical outcomes analysis. Notable contributions include a seminal systematic review on fertility-sparing endometrial cancer treatments referenced in international guidelines. Jannah has attracted $6M+ in collaborative funding and oversees grants such as the 2023 NHMRC-funded ROADMAP trial and a Department of Health-funded study on pediatric sepsis management. Her work spans 50+ peer-reviewed articles across journals like Journal of Medical Internet Research and PLOS One . Professional activities include clinical trials statistics, health economics analysis, and implementation science lectures. She has mentored multiple research teams and maintains an ORCID profile (0000-0002-2208-6584).

• Breast Cancer Prevention
• Spatiotemporal Disease Modelling
• Health Economics
• +3 more

Professor Chengzhong (Michael) Yu is a Research Professor at the Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland. His research focuses on functional nanomaterials for healthcare, energy, and environmental applications. He holds over 400 publications with 36,000+ citations and has received prestigious awards like the NHMRC Leadership Fellowship and ARC Future Fellowship. Education: PhD in Chemistry from Fudan University. Research Interests: Silica-based nanoparticles for drug/gene delivery, energy storage materials (e.g., aluminum-ion batteries), sustainable catalysis, and nano-pesticides for agriculture. His group develops biomaterials for cancer therapy, immunotherapy, and mRNA vaccine platforms. Recent Trends in Publications: Focused on advancing nanocarrier systems for therapeutics, electrocatalytic H₂O₂ synthesis from seawater, and sustainable energy solutions. Collaborates with industry partners like N4 Pharma and Baosteel for translational applications. Awards & Grants: Multiple ARC Discovery/Linkage grants, NHMRC funding, and industry partnerships totaling millions. Notable projects include mRNA delivery platforms and rechargeable aluminum-ion batteries. Supervision & Labs: Mentors over 20 PhD/Master’s students. Leads the Yu Group, collaborating on projects like ‘Designer Nanoparticles for mRNA Factories’ and ‘Nanotechnology for Flystrike Control in Livestock’.

• Nanotechnology
• Materials Science
• Drug Delivery
• +5 more